VIP for mold illness targets inflammatory pathways disrupted by biotoxin

VIP for lung function acts as a bronchodilator and anti-inflammatory

VIP for inflammation targets inflammatory cytokines through neuropeptide pathways, modulating

VIP for circadian rhythm regulates sleep-wake cycles through hypothalamic signaling.

VIP for Shoemaker protocol addresses CIRS-related inflammation by restoring vasoactive

Thymosin Alpha-1 and VIP target distinct pathways—immune modulation versus neuroprotection.

KPV vs VIP: two anti-inflammatory peptides with distinct mechanisms —

VIP (Vasoactive Intestinal Peptide) modulates immune response, inflammation, and neuroprotection

VIP VPAC1/VPAC2 receptor agonism activates G-protein-coupled receptors tied to immune